More Website Templates @ TemplateMonster.com - August 1st 2011!

Welcome to Us!

ildingaportabletestinglab,whichstartedoperationonJanuary30.Thelabsoonachievedthetestingcapabilityof1,000peopleperday. OnMarch16,theCOVID-19vaccinedevelopedbyChenandherteambecamethefirsttobeapprovedbyChinaforclinicaltrials. Thevaccineenteredthesecondf

gmin.BEIJV

About Us

phaseofclinicaltrialsonApril12.ItisthefirstCOVID-19vaccineintheworldthatenteredthesecondphaseofclinicaltrials,accordingtotheWorldHealthOrganization. "Alargeamountofresearchneedstobed7

ING,March8

金沙客户端下载

onebeforewestartclinicaltrialssoastominimizerisks,"ChentoldCCTVinaninterviewonWednesday. ChB Acoronavirusvaccinecandidatedevelopedby7

aunitofChinaNationalPharmaceuticalGroup(Sinopharm)appearedtobesafeandtriggeredantibody-basedimmuneresponsesinearlyandmid-stagetrials,resea1

rcherssaid. Thecandidatehasalreadymovedintoalate-stagetrial,oneofahandfulofcandidatesbeingtestedonseveralthousandpeopletoseeiftheyL

areeffectiveenoughtowinregulatoryapproval. SinopharmistestingthepotentialvaccineintheUnitedArabEmiratesinaPhase3trialexpectedtorecruit15,0005

Testimonials

  • 1

    people,asChinahastoofewnewcasestobeausefultrialsite. Thestate-ownedcompanywillalsosupplythecandidatetoPakistanaspartofatriE

  • 2

    alagreement,theWallStreetJournalreported. Theshotdidnotcauseanyserioussideeffects,accordingtoapaperpublishedonThursdayinth8

  • 3

    eJournaloftheAmericanMedicalAssociation(JAMA)byscientistswhoarepartofSinopharmandotherChina-baseddiseasecontrolauthori7

Toll Free: 1-800 123 45 67

lProtectionandSpD Collect from /

Follow Us